Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial.
Open Access
- 1 September 1985
- Vol. 26 (9), 975-979
- https://doi.org/10.1136/gut.26.9.975
Abstract
Forty patients with biopsy proven chronic active hepatitis were studied, 22 received (+)-cyanidanol-3 in a dose of 3 g daily and 18 placebo. Side effects related to cyanidanol were fever (four patients), haemolysis (one patient) and urticaria (one patient). All side effects subsided on discontinuation of the medication. Cyanidanol had an effect no better than placebo on symptoms, laboratory tests, and histological findings on liver biopsy.Keywords
This publication has 5 references indexed in Scilit:
- (+)-Cyanidanol-3 in the Treatment of Acute Viral Hepatitis: A Randomized Controlled TrialHepatology, 1984
- Effect of (+)–Cyanidanol–3 in Acute Hav, Hbv, and Non–A, Non–B Viral HepatitisHepatology, 1983
- TREATMENT OF ACUTE VIRAL HEPATITIS WITH (+)-CYANIDANOL-3The Lancet, 1977
- Clinical, Biochemical, and Histological Remission of Severe Chronic Active Liver Disease: A Controlled Study of Treatments and Early PrognosisGastroenterology, 1972
- The effect of (+)-catechin on the hepatic level of ATP and the lipid content of liver during experimental steatosisBiochemical Pharmacology, 1972